Physician profile
Evan Smith
NPI 1770112096
$2,559.02
in general payments reported to CMS, 2019-2025
11 companies · $654 in 2025
The $654 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.23 · 2022: $265 · 2023: $445 · 2024: $1,161 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,123 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,122.90 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,222.13 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $275.83 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Medical Device Business Services, INC. | $227.01 | 2024 | Stratafix |
| Janssen Pharmaceuticals, INC | $217.18 | 2022-2024 | Xarelto |
| Amgen INC. | $198.19 | 2024-2025 | Evenity |
| Organogenesis INC. | $125.00 | 2024 | Affinity, Nushield, Novachor |
| Idorsia Pharmaceuticals US INC | $88.59 | 2023 | Quviviq |
| Lilly USA, LLC | $87.01 | 2022 | |
| Angiodynamics, INC. | $83.85 | 2025 | Auryon Laser System 100-120 Vac |
| Abbvie INC. | $18.58 | 2021 | |
| Genentech USA, INC. | $15.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.